Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma

Clinical Trial ID NCT00050102

PubWeight™ 7.55‹?›

🔗 Visit the page for NCT00050102

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma. J Clin Oncol 2015 5.49
2 A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma. Invest New Drugs 2010 2.09
3 Evolving Concepts: Immunity in Oncology from Targets to Treatments. J Oncol 2015 0.81
Next 100